← Leaderboards
Bruce Hill Frank
Thermalin Diabetes, Llc
$9,455,356
Attributed
$9,455,356
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2010–16$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$9,455,356 · 11
By mechanism
R44$5,965,857 · 2
R43$3,489,499 · 9
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinInsulin, Lispro, HumanDesignDrug KineticsBaseProteinsAnalogDoseDrug FormulationsInnovationSmall Business Innovation Research GrantGlycemic ControlDiabetes MellitusStructureZincLifeFamily SuidaeMediatingProgramsRattusTrypsinSafetyAbsorptionReceptor Binding
Grant awards (19)
Enabling implantable artificial pancreas pumps with heat-stable, ultra-rapid insulin$223,490
R43 · FY2016 · DK · contact PI
Enabling implantable artificial pancreas pumps with heat-stable, ultra-rapid insulin$76,501
R43 · FY2016 · DK · contact PI
Fluorolog: A Rapid-Acting Ultra-Concentrated Insulin Formulation$221,045
R44 · FY2015 · DK · contact PI
Optimizing diabetes therapy: re-engineering insulin as a biased agonist$141,297
R43 · FY2015 · DK · contact PI
Optimizing diabetes therapy: re-engineering insulin as a biased agonist$108,696
R43 · FY2015 · DK · contact PI
Chlorolog: Production Scaling and Testing of a Fast-Acting, Ultra-stable Insulin$1,655,309
R44 · FY2014 · DK · contact PI
Fluorolog: A Rapid-Acting Ultra-Concentrated Insulin Formulation$1,275,297
R44 · FY2014 · DK · contact PI
An Ultra-Stable Insulin Analog with Intrinsic Basal-Bolus Action$300,000
R43 · FY2014 · DK · contact PI
Chlorolog: Production Scaling and Testing of a Fast-Acting, Ultra-stable Insulin$1,474,418
R44 · FY2013 · DK · contact PI
Novel Design of a Fast-On/Fast-Off Insulin Analog for Closed-Loop Systems$299,976
R43 · FY2013 · DK · contact PI
Manipulating Aromaticity: characterization of an ultra-rapid insulin analog$263,453
R43 · FY2013 · DK · contact PI
Hexalog: A Rapid-Acting Ultra-Concentrated Insulin Formulation$164,839
R43 · FY2013 · DK · contact PI
Hexalog: A Rapid-Acting Ultra-Concentrated Insulin Formulation$135,161
R43 · FY2013 · DK · contact PI
Manipulating Aromaticity: characterization of an ultra-rapid insulin analog$36,087
R43 · FY2013 · DK · contact PI
Chlorolog: Production and Testing of a Fast-Acting, Ultra-stable Insulin Analog$1,339,788
R44 · FY2012 · DK · contact PI
Manipulating Aromaticity: characterization of an ultra-rapid insulin analog$301,734
R43 · FY2012 · DK · contact PI
Optimized Receptor Binding Profile in an Ultra-Stable, Ultra-Rapid-Acting Insulin$622,539
R43 · FY2011 · DK · contact PI
A Novel "Zinc-Stapled" Long-Acting Insulin Analog$423,635
R43 · FY2010 · DK · contact PI
Halogenated Insulin: a fast-acting, ultra stable analog.$392,091
R43 · FY2010 · DK · contact PI